• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Science and Engineering Laboratories (OSEL) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent
Oct 20108595
Nov 20108592
Dec 20108585
Jan 20118594
Feb 20118591
Mar 20118592
Apr 20118592
May 20118597
Jun 20118594
Jul 20118593
Aug 20118593
Sep 20118595

FY 2011 Overall: 93%

Number of OSEL intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A143
Nov 2010N/A158
Dec 2010N/A105
Jan 2011N/A153
Feb 2011N/A126
Mar 2011N/A166
Apr 2011N/A123
May 2011N/A145
Jun 2011N/A161
Jul 2011N/A135
Aug 2011N/A173
Sep 2011N/A159

FY 2011 Total: 1,747

Total number of OSEL intra- and inter-Office eConsults completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A150
Nov 2010N/A171
Dec 2010N/A123
Jan 2011N/A162
Feb 2011N/A138
Mar 2011N/A181
Apr 2011N/A133
May 2011N/A150
Jun 2011N/A172
Jul 2011N/A145
Aug 2011N/A186
Sep 2011N/A168

FY 2011 Total: 1,879

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.